Success for University of Manchester at the 2017 Northwest Bionow Awards
Around 400 people from the Northwest’s biomedical sector gathered on 30th November at the 16th Northwest Biomedical Awards at Mere Golf and Country Club, Cheshire. This prestigious awards dinner celebrates key achievements from companies and individuals who have made a significant contribution to the biomedical sector during 2017.
University spin-out, Microbiosensor Ltd, which develops disposable point-of-care medical devices, won the Bionow Investment Deal of the Year following a recent £1.4M fundraising round. The deal transforms Microbiosensor from a University spin-out with solid grant funding to a venture-backed business with sufficient capital to CE mark and launch its two lead products. These products have the potential to impact major global medical device markets, and deliver healthcare benefits to vulnerable patient groups, together securing savings of up to £20M per year for each European national healthcare provider.
Professor Curtis Dobson comments: “We were absolutely delighted to receive this prestigious award, which reflects the hard work of all those involved in completing this crucial financing deal for Microbiosensor, and the pivotal role the investment will play in the company bringing its products to market.”
University researchers, Professors Sheena Cruickshank’s, John Mclaughlin’s and Andy Brass’ test for the management and assessment of Inflammatory Bowel Disease won Project of the Year Award. The test provides a non-invasive method to differentiate IBD from IBS and track IBD disease progression reducing the requirement for endoscopies, providing a robust prognosis for improving system management and patient care.
Professors Cruickshank, Mclaughlin and Brass commented: “This is a real honour to have our work recognised by such a prestigious group and we are absolutely delighted. The project represents work across all three schools within the faculty of biology, medicine and health spanning bioinformatics, clinical medicine and fundamental immunology.”
Congratulations also go to University researcher Dr Simon Clark who was shortlisted for the Bionow Promising Technologist of the Year Award and spin-out, SkinBioTherapeutics, shortlisted for the Bionow Investment Deal of the Year Award.
The full list of winners:
Bionow Start Up of the Year Award (Sponsored by RSM)
Bionow Healthcare Project of the Year Award (Sponsored by TRUSTECH)
Sky Medical Technology / James Cook University Hospital South Tees NHS Trust –
Reducing the time to surgery for ankle fracture patients.
Bionow Project of the Year Award (Sponsored by Waters Corporation)
University of Manchester, test for the management and assessment of Inflammatory Bowel Disease
Bionow Product of the Year Award (Sponsored by The Innovation Agency)
Crawford Healthcare – KerraContact Ag
Bionow Technical Service Award (Sponsored by Gateley plc)
Cobra Biologics – Delivery of Technical Services related to the process development and manufacture of Plasmid DNA for Gene Therapy Products in clinical trials
Bionow Business Services Award (Sponsored by World Courier)
Innovation Agency, Healthcare Business Connect
Bionow Promising Technologist of the Year Award (Sponsored by Seqirus)
Peter Chater, Postdoctoral Research Associate, Newcastle University
Bionow Investment Deal of the Year Award (Sponsored by QIAGEN)
Microbiosensor Limited – Series A investment in Microbiosensor by Catapult Ventures and Maven Capital Partners
Bionow Outstanding Contribution Award (Sponsored by Sci-Tech Daresbury)
Dr Steve Little, Chief Executive Officer, Premaitha Health plc
Bionow Company of the Year Award (Sponsored by AstraZeneca)
For more information about Bionow, please visit www.bionow.co.uk
Trackback from your site.